Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 17;8(11):1802.
doi: 10.3390/microorganisms8111802.

Phage Prevalence in the Human Urinary Tract-Current Knowledge and Therapeutic Implications

Affiliations
Review

Phage Prevalence in the Human Urinary Tract-Current Knowledge and Therapeutic Implications

Maciej Żaczek et al. Microorganisms. .

Abstract

Recent metagenomic analyses imply an immense abundance of phages in the human body. Samples collected from different sites (lungs, skin, oral cavity, intestines, ascitic fluid, and urine) reveal a generally greater number of phage particles than that of eukaryotic viruses. The presence of phages in those tissues and fluids reflects the paths they must overcome in the human body, but may also relate to the health statuses of individuals. Besides shaping bacterial metabolism and community structure, the role of phages circulating in body fluids has not been fully understood yet. The lack of relevant reports is especially visible with regard to the human urobiome. Certainly, phage presence and the role they have to fulfill in the human urinary tract raises questions on potential therapeutic connotations. Urinary tract infections (UTIs) are among the most common bacterial infections in humans and their treatment poses a difficult therapeutic dilemma. Despite effective antibiotic therapy, these infections tend to recur. In this review, we summarized the recent data on phage presence in the human urinary tract and its possible implications for health and disease.

Keywords: antibiotic resistance; microbiome; phage circulation; phage therapy; urinary tract; urinary tract infections (UTIs); urobiome; uropathogenic bacteria.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Zheng D., Liwinski T., Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020;30:492–506. doi: 10.1038/s41422-020-0332-7. - DOI - PMC - PubMed
    1. Górski A., Ważna E., Weber-Dąbrowska B., Dąbrowska K., Świtała-Jeleń K., Międzybrodzki R. Bacteriophage translocation. FEMS Immunol. Med Microbiol. 2006;46:313–319. doi: 10.1111/j.1574-695X.2006.00044.x. - DOI - PubMed
    1. Shkoporov A.N., Hill C. Bacteriophages of the Human Gut: The “Known Unknown” of the Microbiome. Cell Host Microbe. 2019;25:195–209. doi: 10.1016/j.chom.2019.01.017. - DOI - PubMed
    1. Dalmasso M., Hill C., Ross R.P. Exploiting gut bacteriophages for human health. Trends Microbiol. 2014;22:399–405. doi: 10.1016/j.tim.2014.02.010. - DOI - PubMed
    1. Enikeeva F.N., Severinov K., Gelfand M.S. Restriction–modification systems and bacteriophage invasion: Who wins? J. Theor. Biol. 2010;266:550–559. doi: 10.1016/j.jtbi.2010.07.006. - DOI - PMC - PubMed

LinkOut - more resources